A Significant Decline During a Bearish Session in Paris
Sopra Steria's stock loses 3.15% at €147.50 in early afternoon, among the biggest declines in the SBF 120. This movement occurs as the broader index drops by 0.8% and the CAC 40 decreases by 0.77%.
The DAX falls more sharply (-2%), in a climate weighed down by the rise of Brent above $92 following new US strikes in Iran. The VIX jumps by nearly 40%, indicating a resurgence of risk aversion in the markets.
Today's decline erases part of the recent progress. Nonetheless, the stock still maintains a gain of nearly 7% over one month and 8% over three months, after a long recovery phase that began at the end of April.
Stock Remains Above Its Moving Averages Despite the Setback
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
Despite today's decline, the stock remains positioned above its three moving averages: +2.9% relative to the MM20 (€143.34), +10.8% relative to the MM50 (€133.17), and nearly 6% above the MM200 (€139.20). An RSI of 64 indicates a still bullish momentum, without excess.
The resistance identified at €155.70, approached last week, was not breached.
According to collected statements, four funds accumulate 3.38% of the capital sold short, an increase of 0.31 points over thirty days. This level, higher than 3%, signals that a portion of institutional investors remains positioned against the stock.
It deserves attention without overinterpretation, as the monthly progression remains modest.
Based on the consensus of surveyed analysts, the stock is trading at about 8.3 times the expected earnings for the current fiscal year, with projected EPS growth of +7.3% next year. The crossing of the resistance at €155.70 remains the next technical milestone to watch.
Relèvement de l'objectif annuel de croissance organique. Cette progression, conjuguée à nos perspectives pour le second semestre, nous permet de relever notre objectif annuel
Risks mentioned
Impact dilutif de 1,8 point lié à l'arrêt du programme SFT, environ 2 points attendus par trimestre
Hausse temporaire du taux de sous-traitance pesant sur la marge en France (9,5 % contre 10,2 %)
Pays-Bas encore en décroissance modérée, Allemagne et Belgique quasi stables
Opportunities identified
Relèvement de l'objectif annuel de croissance organique à +2,0 % / +2,5 %
Croissance forte de l'aéronautique (+12 %) et de la défense-sécurité-espace (+10 %)
Acquisitions de Starion et Nexova créant un acteur européen du spatial et de la cybersécurité
Outlook / guidance
Expected revenue: 5 800 millions d'euros
Management commentary: Flux net de trésorerie disponible d'environ 5 % du chiffre d'affaires
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.